Cantor Fitzgerald Has Weak Forecast for ACRS FY2025 Earnings
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for Aclaris Therapeutics in a research report issued on Tuesday, March 18th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company will post earnings per share of ($0.62) for the year, down […]
More Stories
Government Shutdown Costing US Travel Economy $1 Billion per Week, Group Says
By Jack Phillips The ongoing government shutdown is costing the U.S. travel economy around $1 billion per week in lost...
Burger Chain Installs ‘Tallest and Biggest’ American Flags at Restaurants Nationwide
By Naveen Athrappully Fast food chain Steak ‘n Shake has started installing large American flags at its outlets across the...
US-Backed Kurdish Group, Damascus Agree to Cease-Fire in Northern Syria
By Adam Morrow The Syrian government has agreed to a cease-fire with the Syrian Democratic Forces (SDF), a U.S.-backed, Kurdish-led...
James Comey Pleads Not Guilty to Federal Charges
By Joseph Lord, Lawrence Wilson and Ryan Morgan ALEXANDRIA, Va.—Former FBI Director James Comey pleaded not guilty in federal court...
FBI, LAPD Raid Gang Linked to Mexican Mafia
By Jack Phillips The FBI announced that it and the Los Angeles Police Department (LAPD) raided a Mexican Mafia-linked gang...
Black Rabbit Season 2 Release Date? Jude Law and Jason Bateman’s New Series
Black Rabbit dropped on Netflix in September 2025. It made waves instantly. Raw and packed with tension, this series pulls...